TrialSafety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)
Trial details
- Registry ID
- NCT05125068
- Phase
- Phase 2
ELDN
Eledon Pharmaceuticals
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
3Trials in this database
5Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)NCT05125068 | Eledon Pharmaceuticals | Phase 2 | Terminated | 2023-07-31Actual |
| Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney TransplantationNCT05983770 | Eledon Pharmaceuticals | Phase 2 | Completed | 2025-09-11Actual |
| Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant RecipientsNCT06126380 | Eledon Pharmaceuticals | Phase 2 | Enrolling by invitation | 2029-12Estimated |
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
Trial details
- Registry ID
- NCT05983770
- Phase
- Phase 2
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Trial details
- Registry ID
- NCT06126380
- Phase
- Phase 2
Latest recorded trial changes
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
NCT05983770 · Eledon Pharmaceuticals
Participant count type changed
− Before
Estimated
+ After
Actual
Enrollment · participant count changed
− Before
120 participants (planned)
+ After
127 participants (actual)
Completion date type changed
− Before
Estimated
+ After
Actual
Primary completion date changed
− Before
Mar 2025
+ After
11 Sep 2025
Recruitment status changed
− Before
Active not recruiting
+ After
Completed